Premium
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Hebrew University' Yissum and Israeli Biotech Clearmind Medicine's Psychedelic-Derived Obesity Treatment Presented by Professor Joseph Tam, D.M.D., Ph.D. at Isranalytica 2023...
Israel-Based Clearmind Medicine Successfully Completes Production of CMND-100 Drug Candidate for Clinical Trial Tel Aviv, Israel / Vancouver, Canada, Jan. 10, 2023...
Israel-Based Clearmind Medicine Shows Efficacy of Psychedelic- Derived Obesity Treatment in Pre-Clinical Trial In a series of pre-clinical trials...
Israel-Based Clearmind Medicine Granted U.S. Patent for Psychedelic-Based Alcohol Substitute U.S. Patent and Trademark Office extends protection of Clearmind's...
Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming Clinical Trial VANCOUVER, Canada -- November 23, 2022 -- InvestorsHub NewsWire -- Clearmind...
SciSparc and Clearmind Medicine Inc. Collaboration Yields Positive Results for its Psychedelic Combination Treatment Pre-clinical trials based on the proprietary...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 1.6 | 1.6 | 1.6 | 0 | 0 | CS |
| 4 | 0 | 0 | 1.6 | 1.6 | 1.6 | 0 | 0 | CS |
| 12 | 0 | 0 | 1.6 | 1.6 | 1.6 | 0 | 0 | CS |
| 26 | 0 | 0 | 1.6 | 1.6 | 1.6 | 0 | 0 | CS |
| 52 | -2.05 | -56.1643835616 | 3.65 | 4.67 | 1.25 | 815 | 2.427549 | CS |
| 156 | -17.3 | -91.5343915344 | 18.9 | 330 | 1.25 | 9230 | 23.69502409 | CS |
| 260 | -13.4 | -89.3333333333 | 15 | 330 | 1.25 | 12117 | 23.82595704 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
